Agios Pharmaceuticals, Inc. AGIO
Set alert
29.95 USD -0.60 -1.96%
At close · Nov 2
30.02 +0.07 +0.23%
After hours · Nov 2, 4:00 PM ET
29.83 Day range 31.41
22.24 52-week range 46.00
- YTD
- +10.03%
- 1 year
- -30.74%
- Open
- 30.95
- Prev close
- 30.55
- Mkt cap
- 1.79B
- Vol
- 1.91M
- Avg vol
- 1.08M
- EPS
- -6.87
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 29.83
- High
- 31.41
- Forward P/E
- -7.42
- Beta
- 0.62
- Short ratio
- 5.82
- Inst. own
- 115.39%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 33.62
- 200-d avg
- 31.70
- 1y target
- 45.88
Analyst view
Consensus: buy
Buy
Price target (mean) 45.88 +53.2% upside
Now 29.95
- Target (low)
- 32.00
- Target (mean)
- 45.88
- Target (high)
- 72.00
Ratings (0m) 10 7 buy · 3 hold · 0 sell
- Strong buy0
- Buy7
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.23 | -1.64 – -1.06 | -1.78 | +30.9% | 51.60M | +300.6% | 8 |
| Next quarter | -1.14 | -1.66 – -0.79 | -1.85 | +38.4% | 60.04M | +200.7% | 10 |
| Current year | -5.75 | -6.68 – -5.28 | -7.12 | +19.2% | 177.17M | +227.9% | 8 |
| Next year | -3.75 | -4.90 – -2.09 | -5.77 | +35.0% | 347.42M | +96.1% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 21, 2026 | B of A Securities | Maintained | Buy | Buy |
| Aug 7, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 31, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 31, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 30, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 21, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 7, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 7, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jun 15, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 11, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| May 29, 2026 | B of A Securities | Maintained | Buy | Buy |
| Apr 30, 2026 | Truist Securities | Maintained | Buy | Buy |
| Apr 21, 2026 | B of A Securities | Maintained | Buy | Buy |
| Apr 20, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 6, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Apr 1, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Mar 5, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jan 6, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Dec 26, 2025 | Leerink Partners | Maintained | Outperform | Outperform |
| Dec 24, 2025 | Truist Securities | Maintained | Buy | Buy |
| Dec 24, 2025 | B of A Securities | Maintained | Buy | Buy |
| Dec 24, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 26, 2025 | Citigroup | Initiated | — | Buy |
| Nov 24, 2025 | Truist Securities | Initiated | — | Buy |
| Nov 21, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Nov 20, 2025 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Nov 20, 2025 | B of A Securities | Maintained | Buy | Buy |